Literature DB >> 28052222

Limits to Precision Cancer Medicine.

Ian F Tannock1, John A Hickman2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28052222     DOI： 10.1056/NEJMc1613563

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  The evidence framework for precision cancer medicine.

Authors:  Jeffrey A Moscow; Tito Fojo; Richard L Schilsky
Journal:  Nat Rev Clin Oncol       Date:  2017-12-19       Impact factor: 66.675

Review 2.  Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.

Authors:  Mark Lawler; Deborah Alsina; Richard A Adams; Annie S Anderson; Gina Brown; Nicola S Fearnhead; Stephen W Fenwick; Stephen P Halloran; Daniel Hochhauser; Mark A Hull; Viktor H Koelzer; Angus G K McNair; Kevin J Monahan; Inke Näthke; Christine Norton; Marco R Novelli; Robert J C Steele; Anne L Thomas; Lisa M Wilde; Richard H Wilson; Ian Tomlinson
Journal:  Gut       Date:  2018-01       Impact factor: 23.059

3.  Proteogenomics of Colorectal Cancer Liver Metastases: Complementing Precision Oncology with Phenotypic Data.

Authors:  Bernhard Blank-Landeshammer; Vincent R Richard; Georgia Mitsa; Maud Marques; André LeBlanc; Laxmikanth Kollipara; Ingo Feldmann; Mathilde Couetoux du Tertre; Karen Gambaro; Suzan McNamara; Alan Spatz; René P Zahedi; Albert Sickmann; Gerald Batist; Christoph H Borchers
Journal:  Cancers (Basel)       Date:  2019-12-01       Impact factor: 6.639

Review 4.  Panomics for Precision Medicine.

Authors:  Charanjit Sandhu; Alia Qureshi; Andrew Emili
Journal:  Trends Mol Med       Date:  2017-12-05       Impact factor: 15.272

5.  Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.

Authors:  Matthew Alderdice; Susan D Richman; Simon Gollins; James P Stewart; Chris Hurt; Richard Adams; Amy Mb McCorry; Aideen C Roddy; Dale Vimalachandran; Claudio Isella; Enzo Medico; Tim Maughan; Darragh G McArt; Mark Lawler; Philip D Dunne
Journal:  J Pathol       Date:  2018-03-25       Impact factor: 7.996

6.  Use of a Targeted Exome Next-Generation Sequencing Panel Offers Therapeutic Opportunity and Clinical Benefit in a Subset of Patients With Advanced Cancers.

Authors:  Scott Kopetz; Kenna R Mills Shaw; J Jack Lee; Jiexin Zhang; Beate Litzenburger; Vijaykumar Holla; Walter Kinyua; Emily Broaddus; Molly S Daniels; Funda Meric-Bernstam; Russell R Broaddus
Journal:  JCO Precis Oncol       Date:  2019-03-08

Review 7.  Harnessing cell-free DNA: plasma circulating tumour DNA for liquid biopsy in genitourinary cancers.

Authors:  Manuel Caitano Maia; Meghan Salgia; Sumanta K Pal
Journal:  Nat Rev Urol       Date:  2020-03-17       Impact factor: 14.432
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.